Concurrent duodenal manometric and impedance recording to evaluate the effects of hyoscine on motility and flow events, glucose absorption, and incretin release

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 292, Issue 4, 2007, Pages

  Chaikomin, Reawika ^a   Keng, Liang Wu ^a   Doran, Selena ^a   Jones, Karen L ^a   Smout, Andre J P M ^b   Renooij, Willem ^b   Holloway, Richard H ^a   Meyer, James H ^a   Horowitz, Michael ^a   Rayner, Christopher K ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Anticholinergic; Glucagon like peptide 1; Glucose dependent insulinotropic polypeptide; Small intestine

Indexed keywords

3 METHYLGLUCOSE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; SCOPOLAMINE BUTYL BROMIDE;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFECT; DUODENUM; GLUCOSE ABSORPTION; GLUCOSE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; IMPEDANCE; INTESTINE MOTILITY; INTESTINE PRESSURE; MANOMETRY; NORMAL HUMAN; PRIORITY JOURNAL;

3-O-METHYLGLUCOSE; ADULT; BLOOD GLUCOSE; BUTYLSCOPOLAMMONIUM BROMIDE; CASE-CONTROL STUDIES; DUODENUM; ELECTRIC IMPEDANCE; GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HUMANS; INSULIN; INTESTINAL ABSORPTION; MALE; MANOMETRY; MUSCARINIC ANTAGONISTS; PERISTALSIS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; TIME FACTORS;

EID: 34147188470     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00519.2006     Document Type: Article

References (49)

1. Ahren B, Holst JJ. The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia. Diabetes 50: 1030-1038, 2001.
2. Anini Y, Brubaker PL. Muscarinic receptors control glucagon-like peptide 1 secretion by human endocrine L cells. Endocrinology 144: 3244-3250, 2003.
3. Anini Y, Hansotia T, Brubaker PL. Muscarinic receptors control postprandial release of glucagon-like peptide-1: in vivo and in vitro studies in rats. Endocrinology 143: 2420-2426, 2002.
4. Aschoff AJ, Gorich J, Sokiranski R, Rieber A, Brambs HJ, Kramer SC. Pancreas: does hyoscyamine butylbromide increase the diagnostic value of helical CT? Radiology 210: 861-864, 1999.
5. Balks HJ, Holst JJ, von zur Muhlen A, and Brabant G. Rapid oscillations in plasma glucagon-like peptide-1 (GLP-1) in humans: cholinergic control of GLP-1 secretion via muscarinic receptors. J Clin Endocrinol Metab 82: 786-790, 1997.
6. Berthoud HR, Jeanrenaud B. Sham feeding-induced cephalic phase insulin release in the rat. Am J Physiol Endocrinol Metab 242: E280-E285, 1982.
7. Chaikomin R, Doran S, Jones KL, Feinle-Bisset C, O'Donovan D, Rayner CK, Horowitz M. Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects. Am J Physiol Endocrinol Metab 289: E504-E507, 2005.
8. Cherbut C, Bruley des Varannes S, Schnee M, Rival M, Galmiche JP, and Delort-Laval J. Involvement of small intestinal motility in blood glucose response to dietary fibre in man. Br J Nutr 71: 675-685, 1994.
9. Cooper H, Levitan R, Fordtran JS, Ingelfinger FJ. A method for studying absorption of water and solute from the human small intestine. Gastroenterology 54, Suppl: 783-787, 1968.
10. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993.
11. Deacon CF. What do we know about the secretion and degradation of incretin hormones? Regul Pept 128: 117-124, 2005.
12. Defilippi C, Gomez E. Effect of casein and casein hydrolysate on small bowel motility and D-xylose absorption in dogs. Neurogastroenterol Motil 7: 229-234, 1995.
13. Del Prato S. In search of normoglycaemia in diabetes: controlling postprandial glucose. Int J Obes Relat Metab Disord 26, Suppl 3: S9-17, 2002.
14. Duchman SM, Ryan AJ, Schedl HP, Summers RW, Bleiler TL, Gisolfi CV. Upper limit for intestinal absorption of a dilute glucose solution in men at rest. Med Sci Sports Exerc 29: 482-488, 1997.
15. Eissele R, Goke R, Willemer S, Harthus HP, Vermeer H, Arnold R, Goke B. Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Invest 22: 283-291, 1992.
16. Elson EM, Campbell DM, Halligan S, Shaikh I, Davitt S, Bartram CI. The effect of timing of intravenous muscle relaxant on the quality of double-contrast barium enema. Clin Radiol 55: 395-397, 2000.
17. Fioramonti J, Bueno L, Ruckebusch M. Blood sugar oscillations and duodenal migrating myoelectric complexes. Am J Physiol Gastrointest Liver Physiol 242: G15-G20, 1982.
18. Fordtran JS, Clodi PH, Soergel KH, Ingelfinger FJ. Sugar absorption tests, with special reference to 3-0-methyl-D-glucose and D-xylose. Ann Intern Med 57: 883-891, 1962.
19. Greenberg GR, Pokol-Daniel S. Neural modulation of glucose-dependent insulinotropic peptide (GIP) and insulin secretion in conscious dogs. Pancreas 9: 531-535, 1994.
20. Heddle R, Fone D, Dent J, Horowitz M. Stimulation of pyloric motility by intraduodenal dextrose in normal subjects. Gut 29: 1349-1357, 1988.
21. Herxheimer A, Haefeli L. Human pharmacology of hyoscine butylbromide. Lancet ii: 418-421, 1966.
22. Holdsworth CD, Dawson AM. The absorption of monosaccharides in man. Clin Sci 27: 371-379, 1964.
23. Horowitz M, Cunningham KM, Wishart JM, Jones KL, Read NW. The effect of short-term dietary supplementation with glucose on gastric emptying of glucose and fructose and oral glucose tolerance in normal subjects. Diabetologia 39: 481-486, 1996.
24. Horowitz M, Edelbroek MA, Wishart JM, Straathof JW. Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects. Diabetologia 36: 857-862, 1993.
25. Imam H, Sanmiguel C, Larive B, Bhat Y, Soffer E. Study of intestinal flow by combined videofluoroscopy, manometry, and multiple intraluminal impedance. Am J Physiol Gastrointest Liver Physiol 286: G263-G270, 2004.
26. Jones KL, Horowitz M, Carney BI, Wishart JM, Guha S, Green L. Gastric emptying in early noninsulin-dependent diabetes mellitus. J Nucl Med 37: 1643-1648, 1996.
27. +/D-glucose cotransporter activity in mouse small intestine. J Pharm Pharmacol 52: 679-686, 2000.
28. Lewis LD, Fordtran JS. Effect of perfusion rate on absorption, surface area, unstirred water layer thickness, permeability, and intraluminal pressure in the rat ileum in vivo. Gastroenterology 68: 1509-1516, 1975.
29. Little TJ, Doran S, Meyer JH, Smout AJ, O'Donovan DG, Wu KL, Jones KL, Wishart J, Rayner CK, Horowitz M, and Feinle-Bisset C. The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposed. Am J Physiol Endocrinol Metab 291: E647-E655, 2006.
30. Merio R, Festa A, Bergmann H, Eder T, Eibl N, Stacher-Janotta G, Weber U, Budka C, Heckenberg A, Bauer P, Francesconi M, Schernthaner G, Stacher G. Slow gastric emptying in type I diabetes: relation to autonomic and peripheral neuropathy, blood glucose, and glycemic control. Diabetes Care 20: 419-423, 1997.
31. Modigliani R, Bernier JJ. Absorption of glucose, sodium, and water by the human jejunum studied by intestinal perfusion with a proximal occluding balloon and at variable flow rates. Gut 12: 184-193, 1971.
32. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353: 2643-2653, 2005.
33. Nguyen HN, Silny J, Matern S. Multiple intraluminal electrical impedancometry for recording of upper gastrointestinal motility: current results and further implications. Am J Gastroenterol 94: 306-317, 1999.
34. Nguyen HN, Silny J, Wuller S, Marschall HU, Rau G, Matern S. Abnormal postprandial duodenal chyme transport in patients with long standing insulin dependent diabetes mellitus. Gut 41: 624-631, 1997.
35. Nguyen HN, Silny J, Wuller S, Marschall HU, Rau G, Matern S. Chyme transport patterns in human duodenum, determined by multiple intraluminal impedancometry. Am J Physiol Gastrointest Liver Physiol 268: G700-G708, 1995.
36. O'Donovan DG, Doran S, Feinle-Bisset C, Jones KL, Meyer JH, Wishart JM, Morris HA, Horowitz M. Effect of variations in small intestinal glucose delivery on plasma glucose, insulin, and incretin hormones in healthy subjects and type 2 diabetes. J Clin Endocrinol Metab 89: 3431-3435, 2004.
37. Ohneda A, Kobayashi T, Nihei J, Imamura M, Naito H, Tsuchiya T. Role of vagus nerve in secretion of gastric inhibitory polypeptide in dogs. Tohoku J Exp Med 147: 183-190, 1985.
38. Rayner CK, Schwartz MP, van Dam PS, Renooij W, de Smet M, Horowitz M, Smout AJ, Samsom M. Small intestinal glucose absorption and duodenal motility in type 1 diabetes mellitus. Am J Gastroenterol 97: 3123-3130, 2002.
39. Rayner DV. The relationships between glucose absorption and insulin secretion and the migrating myoelectric complex in the pig. Exp Physiol 76: 67-76, 1991.
40. Samsom M, Benninga M, vanSteenderen L, Renooij W, de Smet M, Akkermans LMA, Smout AJPM. Inhibition of small intestinal motility decreases glucose absorption in humans (Abstract). Gastroenterology 116: G4659, 1999.
41. Samsom M, Smout AJ, Hebbard G, Fraser R, Omari T, Horowitz M, Dent J. A novel portable perfused manometric system for recording of small intestinal motility. Neurogastroenterol Motil 10: 139-148, 1998.
42. Sarr MG, Kelly KA, Phillips SF. Canine jejunal absorption and transit during interdigestive and digestive motor states. Am J Physiol Gastrointest Liver Physiol 239: G167-G172, 1980.
43. Savoye G, Savoye-Collet C, Oors J, Smout AJ. Interdigestive transpyloric fluid transport assessed by intraluminal impedance recording. Am J Physiol Gastrointest Liver Physiol 284: G663-G669, 2003.
44. Savoye-Collet C, Savoye G, Smout A. Determinants of transpyloric fluid transport: a study using combined real-time ultrasound, manometry, and impedance recording. Am J Physiol Gastrointest Liver Physiol 285: G1147-G1152, 2003.
45. Schirra J, Katschinski M, Weidmann C, Schafer T, Wank U, Arnold R, Goke B. Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest 97: 92-103, 1996.
46. Schwartz MP, Samsom M, Renooij W, van Steenderen LW, Benninga MA, van Geenen EJ, van Herwaarden MA, de Smet MB, Smout AJ. Small bowel motility affects glucose absorption in a healthy man. Diabetes Care 25: 1857-1861, 2002.
47. Sjovall H, Hagman I, Abrahamsson H. Relationship between interdigestive duodenal motility and fluid transport in humans. Am J Physiol Gastrointest Liver Physiol 259: G348-G354, 1990.
48. Stacher G, Bergmann H, Havlik E, Schmierer G, Schneider C. Effects of oral cyclotropium bromide, hyoscine N-butylbromide and placebo on gastric emptying and antral motor activity in healthy man. Gut 25: 485-490, 1984.
49. The UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352: 837-853, 1998.